Today's Agenda
FDA Ruling Expected</br></br>On Avastin Indication</br></br>The FDA is expected to decide whether to add breast-cancer treatment to the approved uses of Genentech Inc.'s Avastin, an effort that has split the cancer community. An agency advisory committee voted against approval in December.</br></br>Fed's Fisher to Speak;</br></br>PG&E Reports Results